Please use this identifier to cite or link to this item:
Title: Real-world treatment in patients with HER2+ metastatic breast cancer : Treatment decisions in HER2+ mBC.
Issue Date: Feb-2018
Citation: Breast Cancer Res. Treat..2018 Feb;(168)1:197-205
Abstract: The landscape of HER2+ metastatic breast cancer (mBC) treatment is changing due to the availability of new anti-HER2 drugs. The purpose of this study was to assess the current treatment patterns and sequences used in HER2+ mBC in the real-world setting. Secondary objectives were to describe the factors that influence the decision to prescribe a first and second-line antitumour treatment.
PMID: 29170976
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Princesa > Artículos

Files in This Item:
File Description SizeFormat 
PMC5847072.pdf693.17 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.